Finding a Role for GLP-1 RAs, Incretin Therapies in Heart Failure, with Muthiah Vaduganathan, MD, MPH ByMuthiah Vaduganathan, MD, MPH Patrick Campbell November 19th 2024 Muthiah Vaduganathan, MD, MPH, discusses the need for cardiology to embrace a role for GLP-1 receptor agonists and incr...
Finding a Role for GLP-1 RAs, Incretin Therapies in Heart Failure, with Muthiah Vaduganathan, MD, MPH ByMuthiah Vaduganathan, MD, MPH Patrick Campbell November 19th 2024 Muthiah Vaduganathan, MD, MPH, discusses the need for cardiology to embrace a role for GLP-1 receptor agonists and incr...
whether your metformin strength needs to be adjusted before adding a GLP-1, and whether you fit the profile of a T2D patient who needs to shed some weight and take particular care of your heart and vascular
Report on the 57th Scientific Sessions of American Heart Association and the Sixth International Conference and Workshop of Cardiovascular System Dynamics ... M Hori - BME 被引量: 0发表: 1985年 Report on the 57th Scientific Sessions of American Heart Association and the Sixth International Confere...
For the first time in a decade, the American Stroke Association, a division of the American Heart Association, has updated itsGuideline for the Primary Prevention of Strokewith a series of new recommendations for health-care professionals and clinicians to screen for therisk of strok...
Eur Heart J. 2023;44:4043–140. Article CAS PubMed Google Scholar Zheng RJ, Wang Y, Tang JN, Duan JY, Yuan MY, Zhang JY. Association of SGLT2 inhibitors with risk of atrial fibrillation and stroke in patients with and without type 2 diabetes: a systemic review and meta-analysis of ...
ADA, American Diabetes Association; ASCVD, atherosclerotic cardiovascular disease; CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate; GLP-1, glucagon-like peptide 1; HbA1c, glycated hemoglobin; HF, heart failure; KDIGO: Kidney Disease: Improving Global Outcomes; MACE, major adver...
The Pooled Cohort Equations (PCEs), developed by the American Heart Association (AHA) and American College of Cardiology, have been widely used since 2013 to estimate 10-year atherosclerotic cardiovascular disease (ASCVD) risk and guide statin therapy. Recently, the AHA introduced the Predicting Ri...
Lewis J.E., Arheart K.L., LeBlanc W.G.,et al. Food label use and awareness of nutritional information and recommendations among persons with chronic disease Am J Clin Nutr, 90 (2009), pp. 1351-1357 [EL 3; SS] View PDF American Dietetic Association ...
(ER) stress, a known promoter of cardiovascular disease. Contemporary anti-hyperglycemic drugs such as glucagon-like peptide 1 (GLP-1) receptor agonists and sodium–glucose cotransporter 2 (SGLT-2) inhibitors simultaneously inhibit oxidative stress and ER stress in human coronary artery endothelial ...